FWA
SLS icon

Fulcrum Wealth Advisors’s SELLAS Life Sciences SLS Stock Holding History

Fulcrum Wealth Advisors’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,500
Closed -$65.6K – 89
2026
Q1 		$65.6K Buy
15,500
+3,000
+24% +$13.4K 0.05% 71
2025
Q4 		$47.1K Buy
+12,500
New +$24.3K 0.04% 68

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IW
Instrumental Wealth Tampa, Florida $198M AUM 24.07% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return

Fulcrum Wealth Advisors's SLS Position: Q2 2026 in Review

Fulcrum Wealth Advisors reduced its SELLAS Life Sciences (SLS) stake by 33% in Q2 2026, selling an estimated $249K and leaving 73,253 shares worth $1.08M. The position accounts for 0.83% of the portfolio, ranked #29.

Fulcrum Wealth Advisors first reported a position in SLS in Q4 2025 and has held it in 3 quarters since. 48 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Fulcrum Wealth Advisors held 73,253 shares of SELLAS Life Sciences worth $1.08M as of Q2 2026.
  • Fulcrum Wealth Advisors sold 35,998 SELLAS Life Sciences shares in Q2 2026, an estimated $249K.
  • SELLAS Life Sciences made up 0.83% of Fulcrum Wealth Advisors's portfolio in Q2 2026, its #29 holding.
  • Fulcrum Wealth Advisors first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 48 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Fulcrum Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.